Why is Balaxi Pharma falling/rising?

As of 11-Nov, Balaxi Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 39.97, which reflects a decrease of Rs. 1.75 or 4.19%. The stock has hit a new 52-week low of Rs. 39.81 today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has underperformed its sector by 2.17% today, and there has been a notable drop in investor participation, with delivery volume falling by 27.01% compared to the 5-day average. Over various time frames, the stock has shown significant underperformance, with a year-to-date decline of 44.72% and a staggering 72.09% drop over the past five years, indicating persistent weakness without any available positive factors to counterbalance this trend.
In the broader market context, the Sensex has shown a positive return of 0.38% over the past week, contrasting sharply with Balaxi Pharmaceuticals' decline of 6.59% during the same period. This divergence highlights the stock's struggles relative to the overall market performance, as it continues to lag significantly behind the benchmark, which has gained 8.67% year-to-date. The stark contrast between the stock's performance and that of the benchmark suggests that investor sentiment towards Balaxi Pharmaceuticals is weak, further exacerbated by the lack of positive developments or factors that could potentially support a recovery.